Talus Bioscience, Inc. — Form D

Talus Bioscience, Inc. of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-12. The offering totals $11.3M, of which $9.4M was reported sold. Industry: Other Technology.

Offering

• Filed: 2024-08-12
• Form: D
• Accession: 0002033246-24-000001
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $11.3M
• Amount sold: $9.4M
• Remaining: $1.9M
• Investors: 11
• Date of first sale: 2024-07-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-521283

Issuer

• Name: Talus Bioscience, Inc.
• CIK: 0002033246
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 550 17th Avenue, Suite 550, Seattle, WA, 98122
• Phone: (206) 487-1062

Officers, directors & promoters (8)

More

• CIK 2033246 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search